0001104659-24-063903.txt : 20240521 0001104659-24-063903.hdr.sgml : 20240521 20240521170437 ACCESSION NUMBER: 0001104659-24-063903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240517 FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chaturvedi Pravin R CENTRAL INDEX KEY: 0001916935 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 24970526 MAIL ADDRESS: STREET 1: C/O JAGUAR HEALTH INC., 200 PINE STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 4 1 tm2414996-4_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-05-17 0 0001585608 Jaguar Health, Inc. JAGX 0001916935 Chaturvedi Pravin R C/O JAGUAR HEALTH, INC. 200 PINE STREET, SUITE 400 SAN FRANCISCO CA 94104 0 1 0 0 Chief Scientific Officer 0 Common Stock 2024-05-17 4 M 0 871 A 2141 D Restricted stock units 2024-05-17 4 M 0 871 0 D Common Stock 871 871 D Restricted stock units convert into common stock on a one-for-one basis. On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. The restricted stock units were originally approved by the issuer's board of directors on March 28, 2022 and previously reported as covering 195,934 shares, but were adjusted to reflect the January 2023 Reverse Stock Split. The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice. /s/ Jonathan Wolin, Attorney-in-Fact 2024-05-21